Zydus Lifesciences Q2 net profit falls 26.6% to Rs 925.5 crore

New Delhi: Zydus Lifesciences on Wednesday reported a 26.6% decline in consolidated net profit to ₹925.5 crore in the September quarter, weighed down by higher expenses.

The company had posted a net profit of ₹1,260.9 crore in the corresponding period of the previous fiscal year, it said in a regulatory filing.

Read more: Dabur India Q2 Results: Profit rises 12% YoY to Rs 506 crore, revenue up 12%; co declares interim dividend of Rs 3.50/share


Revenue from operations rose 29.2% to ₹7,909.6 crore during the quarter from ₹6,123.2 crore a year earlier. Total expenses increased sharply to ₹6,806.6 crore during the quarter from ₹4,509 crore in the same period last year.

Read more: Lenskart Q2 Results: Profit zooms 122% YoY to Rs 227 crore; revenue grows 36%

During the quarter, the pharmaceuticals business accounted for 83% of the company's sales, Zydus said in a statement.

Its India formulations business reported revenue of ₹1,884.4 crore, up 18% year-on-year, while the North America formulations business posted revenue of ₹3,314.5 crore.